Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Depreciation and Depletion: 2020-2025

Historic Depreciation and Depletion for Relay Therapeutics (RLAY) over the last 6 years, with Sep 2025 value amounting to $748,000.

  • Relay Therapeutics' Depreciation and Depletion fell 45.28% to $748,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 22.03%. This contributed to the annual value of $5.5 million for FY2024, which is 3.70% up from last year.
  • Latest data reveals that Relay Therapeutics reported Depreciation and Depletion of $748,000 as of Q3 2025, which was down 25.35% from $1.0 million recorded in Q2 2025.
  • Relay Therapeutics' 5-year Depreciation and Depletion high stood at $1.4 million for Q1 2024, and its period low was $748,000 during Q3 2025.
  • In the last 3 years, Relay Therapeutics' Depreciation and Depletion had a median value of $1.3 million in 2024 and averaged $1.2 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 39.54% in 2023, then slumped by 45.28% in 2025.
  • Quarterly analysis of 5 years shows Relay Therapeutics' Depreciation and Depletion stood at $1.0 million in 2021, then increased by 12.77% to $1.2 million in 2022, then increased by 17.92% to $1.4 million in 2023, then fell by 2.98% to $1.3 million in 2024, then plummeted by 45.28% to $748,000 in 2025.
  • Its Depreciation and Depletion was $748,000 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.2 million in Q1 2025.